PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Protalix BioTherapeutics, Inc.
Filed: May 9, 2012
Period of Report: June 17, 2012
Accession Number: 0001144204-12-027203

View Document ↗ View on SEC.gov ↗